Skip to main content

Table 1 Distribution of patient and tumor characteristics in the study cohort

From: The effect of intravesical Bacillus Calmette-Guerin (BCG) treatment on sperm parameters in non-muscle-invasive bladder cancer patients

Age (years) (Mean ± SD, Min–Max)

54.7 ± 6.3

35–61

Stage at TUR-B

n

%

CIS

1

4.3%

T1 HG

4

17.4%

T1 HG + CIS

6

26.1%

Ta HG

9

39.1%

Ta LG

3

13.0%

Concomitant disease

 None

13

56.5%

 AS

1

4.35%

 HT

6

26.1%

 COPD

3

13.05%

  1. This table presents the demographic and clinical characteristics of the study participants, including tumor stage at transurethral resection of the bladder tumor (TUR-B) and the presence of comorbidities. Data are expressed as median (min–max) for continuous variables and as frequencies (%) for categorical variables
  2. CIS Carcinoma in situ, HG High grade, LG Low grade, TUR-B Transurethral resection of bladder tumor, AS Ankylosing Spondylitis, HT Hypertension, COPD Chronic obstructive pulmonary disease